SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 320 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $229,000 | -66.3% | 1,327 | -77.6% | 0.00% | -72.7% |
| Q4 2014 | $679,000 | -61.2% | 5,911 | -47.2% | 0.01% | -62.1% |
| Q3 2014 | $1,750,000 | -9.0% | 11,200 | -28.2% | 0.03% | -12.1% |
| Q2 2014 | $1,924,000 | +9.3% | 15,600 | -8.2% | 0.03% | 0.0% |
| Q1 2014 | $1,761,000 | +68.8% | 17,000 | +46.6% | 0.03% | +57.1% |
| Q4 2013 | $1,043,000 | +102.5% | 11,600 | +50.6% | 0.02% | +90.9% |
| Q3 2013 | $515,000 | – | 7,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |